Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 143.00
Bid: 143.00
Ask: 137.50
Change: -0.50 (-0.35%)
Spread: -5.50 (-3.846%)
Open: 143.00
High: 145.00
Low: 143.00
Prev. Close: 143.50
MACF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Oversubscribed Placing

18 Sep 2017 12:42

RNS Number : 0514R
Macfarlane Group PLC
18 September 2017
 

THIS ANNOUNCEMENT, AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES OF AMERICA, CANADA, THE REPUBLIC OF SOUTH AFRICA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN MACFARLANE GROUP PLC OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH, ANY INVESTMENT DECISION IN RESPECT OF MACFARLANE GROUP PLC.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION ("MAR"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED IN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE INFORMATION, AS PERMITTED BY MAR. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.

 

18 September 2017

 

MACFARLANE GROUP PLC

 

("Macfarlane" or the "Company")

Result of Oversubscribed Placing

 

Following the earlier announcement this morning that Macfarlane has entered into a conditional agreement to acquire Greenwoods and is conditionally raising £8 million through a placing of new ordinary shares in the Company, Macfarlane is pleased to announce the completion of an oversubscribed Placing.

 

A total of 12,121,212 Placing Shares have been placed at a Placing Price of 66 pence per Placing Share (the "Placing Price"), representing a discount of approximately 1.1 per cent. to the closing price on 15 September 2017, being the last practicable date before this announcement.

 

Based on the Placing Price, the gross proceeds of the Placing are £8 million. The Placing Shares and the Vendor Shares will represent approximately 13.5 per cent. of the enlarged issued ordinary share capital of the Company.

Application will be made to the UKLA and the London Stock Exchange for the Placing Shares and Vendor Shares, a total of 21,212,121 Ordinary Shares, to be admitted to the Official List and to trading on the Main Market ("Admission").

It is expected that Admission will become effective and that dealings for normal settlement in the Placing Shares and Vendor Shares on the Main Market will commence at 8.00 a.m. on 21 September 2017.

Related party transactions

The Company has today been notified that the following substantial shareholders of the Company have agreed to acquire Placing Shares pursuant to the terms of the Placing at the Placing Price. Following Admission, their beneficial interests will be as follows:

 

Shareholder

No. of Placing Shares acquired pursuant to the terms of the Placing and aggregate value at Placing Price

Resulting holding following Admission

% of enlarged issued voting share capital

Rights & Issues Investment Trust plc ("Rights & Issues")

508,632

 

£335,697

17,250,000

10.95%

Hargreave Hale Limited ("Hargreave")

833,333

£550,000

16,176,002

10.27%

Miton Asset Management Limited ("Miton")

1,212,121

£800,000

16,427,358

10.43%

The Placing is deemed to be a related party transaction as described in the Listing Rules. As the participation of Rights & Issues, Hargreave and Miton in the Placing is less than 5% under the relevant class tests in the Listing Rules, shareholder approval is not required under Listing Rule 11.

However the transaction falls within Listing Rule 11.1.10R and as such the Company is required to obtain from Arden as Sponsor to the Company confirmation the terms of the proposed transaction or arrangement with the related party are fair and reasonable as far as the shareholders of the Company (the "Shareholders") are concerned.

The Directors, who have consulted with Arden in its capacity as Financial Adviser and Sponsor to the Company, consider the Placing to be fair and reasonable insofar as Shareholders are concerned and to be in the best interests of the Company and its Shareholders as a whole.

Total voting rights

Post completion of the Acquisition, and the issue of the Placing Shares and Vendor Shares Macfarlane will have 157,547,618 Ordinary Shares in issue. The Company does not hold any Ordinary Shares in treasury. Therefore, on that basis, the total number of ordinary shares and voting rights in the Company will be 157,547,618 post Admission.

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

All terms in this announcement have the meaning given to them in the announcement made by the Company at 7 a.m. on 18 September 2017 unless otherwise defined herein.

 

Further enquiries:

Macfarlane Group

Tel: 0141 333 9666

Graeme Bissett

Chairman

Peter Atkinson

Chief Executive

John Love

Finance Director

Arden Partners

Tel: 0207 614 5900

Steve Douglas / Ciaran Walsh

Corporate Finance

 

Matt Groves

Corporate Broking

 

 

 

Spreng Thomson

Tel: 0141 548 5191

Callum Spreng

Mob: 07803 970103

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIOKFDNDBKDFCD
Date   Source Headline
25th Apr 202410:36 amRNSNotice of Annual General Meeting
11th Apr 20244:56 pmRNSHolding(s) in Company
8th Apr 20241:59 pmRNSHolding(s) in Company
3rd Apr 202411:15 amRNSHolding(s) in Company
28th Mar 20242:22 pmRNSDirector/PDMR Shareholding
28th Mar 202411:15 amRNSDirector / PDMR Shareholding & EBT share purchase
19th Mar 20247:00 amRNSIssue of Shares
15th Mar 20244:45 pmRNSHolding(s) in Company
13th Mar 20247:00 amRNSAcquisition of Allpack Packaging Supplies Limited
29th Feb 20247:00 amRNSAnnual Results 2023
26th Feb 20241:46 pmRNSInvestor Presentation via Investor Meet Company
14th Feb 202410:29 amRNSNotice of Results
13th Dec 202310:00 amRNSBoard Changes
23rd Nov 20237:00 amRNSTrading Update
31st Oct 20238:19 amRNSHolding(s) in Company
2nd Oct 20237:00 amRNSAcquisition of B&D 2010 Group Limited
29th Aug 20237:00 amRNSIssue of Shares
24th Aug 20237:00 amRNSHalf-year Report
8th Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
4th Aug 20237:00 amRNSNotice of Results
6th Jul 20231:29 pmRNSHolding(s) in Company
9th May 20233:08 pmRNSResult of AGM
9th May 20237:00 amRNSAGM Trading Update
2nd May 20237:00 amRNSAcquisition
28th Apr 20235:17 pmRNSNotice of AGM
20th Apr 20235:18 pmRNSHolding(s) in Company
20th Apr 20232:03 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSAnnual Report 2022
27th Mar 202312:29 pmRNSDirector/PDMR Shareholding
6th Mar 20237:00 amRNSAcquisition
23rd Feb 20237:00 amRNSAnnual Results 2022
15th Feb 20237:00 amRNSNotice of Results
29th Nov 20227:00 amRNSDirector/PDMR Shareholding
28th Nov 20227:00 amRNSDirector/PDMR Shareholding
24th Nov 20227:00 amRNSTrading Update
7th Oct 202210:00 amRNSHolding(s) in Company
7th Oct 202210:00 amRNSHolding(s) in Company
27th Sep 20221:57 pmRNSHolding(s) in Company
15th Sep 20227:00 amRNSAppointment of Non-Executive Director
8th Sep 20227:00 amRNSDirector/PDMR Shareholding
25th Aug 20227:16 amRNSHalf-year Report
5th Aug 20227:00 amRNSNotice of Results
19th May 20227:00 amRNSDirector/PDMR Shareholding
17th May 202212:00 pmRNSAcquisition
16th May 20227:00 amRNSIssue of Shares
10th May 20223:24 pmRNSResult of AGM
10th May 202212:00 pmRNSTrading Update
6th Apr 20227:00 amRNSNotice of AGM
5th Apr 20227:00 amRNSDirector/PDMR Shareholding
31st Mar 20227:00 amRNSAnnual Report 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.